These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22095194)

  • 1. Mortality and loss to follow-up in the first year of ART: Malawi national ART programme.
    Weigel R; Estill J; Egger M; Harries AD; Makombe S; Tweya H; Jahn A; Keiser O
    AIDS; 2012 Jan; 26(3):365-73. PubMed ID: 22095194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
    Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O
    Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India.
    Nimkar S; Valvi C; Kadam D; Rewari BB; Kinikar A; Gupte N; Suryavanshi N; Deluca A; Shankar A; Golub J; Bollinger R; Gupta A; Marbaniang I; Mave V
    HIV Med; 2018 Jul; 19(6):395-402. PubMed ID: 29573312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcomes of older HIV-infected patients receiving antiretroviral therapy in Malawi: A retrospective observation cohort study.
    Tweya H; Feldacker C; Heller T; Gugsa S; Ng'ambi W; Nthala O; Kalulu M; Chiwoko J; Banda R; Makwinja A; Phiri S
    PLoS One; 2017; 12(7):e0180232. PubMed ID: 28686636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
    Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who will be lost? Identifying patients at risk of loss to follow-up in Malawi. The DREAM Program Experience.
    Mancinelli S; Nielsen-Saines K; Germano P; Guidotti G; Buonomo E; Scarcella P; Lunghi R; Sangare H; Orlando S; Liotta G; Marazzi MC; Palombi L
    HIV Med; 2017 Sep; 18(8):573-579. PubMed ID: 28150466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study.
    Kerkhoff AD; Sikombe K; Eshun-Wilson I; Sikazwe I; Glidden DV; Pry JM; Somwe P; Beres LK; Simbeza S; Mwamba C; Bukankala C; Hantuba C; Moore CB; Holmes CB; Padian N; Geng EH
    PLoS Med; 2020 May; 17(5):e1003107. PubMed ID: 32401797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
    Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
    PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
    Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
    PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
    Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
    PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of gender and income on survival and retention in a South African antiretroviral therapy programme.
    Cornell M; Myer L; Kaplan R; Bekker LG; Wood R
    Trop Med Int Health; 2009 Jul; 14(7):722-31. PubMed ID: 19413745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric HIV Care Cascade in Southern Mozambique: Missed Opportunities for Early ART and Re-engagement in Care.
    Fernández-Luis S; Nhampossa T; Fuente-Soro L; Augusto O; Casellas A; Bernardo E; Ruperez M; Gonzalez R; Maculuve S; Saura-Lázaro A; Menendez C; Naniche D; Lopez-Varela E
    Pediatr Infect Dis J; 2020 May; 39(5):429-434. PubMed ID: 32091497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records.
    Haas AD; Ruffieux Y; van den Heuvel LL; Lund C; Boulle A; Euvrard J; Orrell C; Prozesky HW; Tiffin N; Lovero KL; Tlali M; Davies MA; Wainberg ML;
    Lancet Glob Health; 2020 Oct; 8(10):e1326-e1334. PubMed ID: 32971055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration.
    Kariminia A; Law M; Davies MA; Vinikoor M; Wools-Kaloustian K; Leroy V; Edmonds A; McGowan C; Vreeman R; Fairlie L; Ayaya S; Yotebieng M; Takassi E; Pinto J; Adedimeji A; Malateste K; Machado DM; Penazzato M; Hazra R; Sohn AH;
    J Int AIDS Soc; 2018 Dec; 21(12):e25215. PubMed ID: 30548817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme.
    Haas AD; van Oosterhout JJ; Tenthani L; Jahn A; Zwahlen M; Msukwa MT; Davies MA; Tal K; Phiri N; Spoerri A; Chimbwandira F; Egger M; Keiser O
    J Int AIDS Soc; 2017 Sep; 20(1):21947. PubMed ID: 28884524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.